Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334,352,960
-
Total 13F shares
-
162,111,422
-
Share change
-
+4,562,443
-
Total reported value
-
$4,215,394,735
-
Put/Call ratio
-
39%
-
Price per share
-
$26.02
-
Number of holders
-
226
-
Value change
-
+$75,696,267
-
Number of buys
-
139
-
Number of sells
-
113
Institutional Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q2 2021
As of 30 Jun 2021,
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) was held by
226 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
162,111,422 shares.
The largest 10 holders included
ARK Investment Management LLC, VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, Avoro Capital Advisors LLC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., WELLINGTON MANAGEMENT GROUP LLP, FRANKLIN RESOURCES INC, BlackRock Inc., and ORBIMED ADVISORS LLC.
This page lists
226
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.